trial

Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) in Schizophrenia

NCTId NCT01315587
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Unknown
Enrollment 30 (estimated)
Sponsored by University of Tehran
Primary completion 2015-11
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Unknown
Enrollment
30 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2011-01
Primary completion
2015-11
Eligibility
ALL · 18 Years · 50 Years

Interventions & indications

Drugs
repetitive Transcranial Magnetic Stimulation (Magstim rapid2 )repetitive Transcranial Magnetic Stimulation (Magstim rapid2)repetitive Transcranial Magnetic Stimulation(Magstim rapid2)

Sponsors

University of TehranLead Sponsor

Sites

1 total
Tehran, Iran

Linked catalysts

1
Repetitive Transcranial Magnetic Stimulation and Intermittent Theta Burst (iTBS) — primary completion2015-11

Facts & assertions

4 sourced
Enrollment
30
Phase
PHASE2
Primary Completion Date
2015-11
Status
UNKNOWN
relationships
The graph out of here
drug
repetitive Transcranial Magnetic Stimulation (Magstim rapid2 )
drug
repetitive Transcranial Magnetic Stimulation (Magstim rapid2)
drug
repetitive Transcranial Magnetic Stimulation(Magstim rapid2)
drug
lead_sponsor
University of Tehran
company
indication
Schizophrenia
indication
Schizophrenia
indication